Interviews available with RTOERO experts, Canadian and international speakers. WHEN: Wednesday, May 15 (7?9PM)Thursday, May 16 (8:30AM?8PM) Friday, May 17 (8:30AM?12:15PM) WHERE: ...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies is pleased to announce the expansion of two research collaborations to align with its recently...
IntelGenx Technologies Corp. (the "Company" or "IntelGenx") announces that, at the annual meeting of shareholders of the Company held on May 7, 2024 (the "Annual Meeting"), shareholders voted in favour of all items of business put forth by the...
Carisma Therapeutics Inc. ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced new data demonstrating preclinical proof of concept using...
NeuroTherapia, an early-stage clinical pharmaceutical company, announced today that it has received a grant from the Alzheimer's Association Part the Cloud program for the development of its first-in-class drug, NTRX-07, for the treatment of...